Fareva Launches New Aerosol Plant
By

By
Fareva Group, a contract manufacturer of household and industrial, cosmetic, and pharmaceutical products, has launched a new aerosol plant at its US site in Richmond, Virginia, following a first-phase investment…

West Launches New Medical Devices Plant
By

By
West Pharmaceutical Services with support from Ardmac, a construction services firm headquartered in Dublin, Ireland, has opened a new medical device facility in Damastown, County Dublin, which was built in response to…

Rondo Expands Box-Packaging Production Capacity
By

By
Rondo AG, an Allschwil, Switzerland-based pharmaceutical packaging company, has expanded its box-packaging production capacity in its factory in Ejpovice, the Czech Republic with the addition of a new die-cutting machine…

AstraZeneca, Lilly Partner for Alzheimer’s Disease Drug
By

By
AstraZeneca and Eli Lilly and Company have entered a worldwide agreement to co-develop MEDI1814, an antibody selective for amyloid-beta 42 (Aβ42) in Phase I trials as a potential treatment for…

Endo Returns Pain Med, Restructures Sales Force
By

By
Endo International has entered into an agreement with its partner, BioDelivery Sciences International (BDSI), a Raleigh, North Carolina-based specialty pharmaceutical company focused on pain and addiction, to return the pain-treatment…

Spark, Selecta in Gene-Therapy Deal Worth Up to $460 Million
By

By
Spark Therapeutics, a Philadelphia-based late clinical-stage gene therapy company, has entered into a license agreement with Selecta Biosciences, a Watertown, Massachusetts-based clinical-stage biopharmaceutical company, for the exclusive worldwide rights to…

Perrigo to Restructure Branded Consumer Healthcare Biz
By

By
Perrigo has announced its intention to restructure the Branded Consumer Healthcare’s Omega Pharma Belgium business, which includes Omega Pharma Belgium NV, Etixx NV, and Biover NV, located in Nazareth, Belgium…

AbbVie, Novartis, and Roche Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from AbbVie, Novartis, and Roche. Editor’s Note: This article is updated on a continuous basis for news…

J&J Ends Transaction Discussions with Actelion
By

By
Johnson & Johnson (J&J) has confirmed that it has ended discussions with Actelion Pharmaceuticals, an Allschwil, Basel, Switzerland-headquartered biopharmaceutical company, regarding a potential transaction. In a company statement, J&J said…

AstraZeneca, Gilead, Novartis, and Sanofi Lead Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors and other related news, featuring news from AstraZeneca, Gilead, Novartis, and Sanofi. Editor’s Note: This article…